Reply to: Chemotherapy benefits in patients with hepatoid adenocarcinoma: A long-term follow-up study on a rare gastric disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reply to: Chemotherapy benefits in patients with hepatoid adenocarcinoma: A long-term follow-up study on a rare gastric disease

Published:2024-09 Issue:9 Volume:50 Page:108407
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Huang Zening,Huang Yingqi,Huang Changming,Li Ping^ORCID

Publisher

Elsevier BV

Reference5 articles.

1. Long-term prognostic benefit of adjuvant chemotherapy for patients with hepatoid adenocarcinoma of the stomach after radical resection: a national multicenter study;Huang;Eur J Surg Oncol,2023

2. Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach;Liu;Am J Surg Pathol,2010

3. Therapeutic approaches to gastric hepatoid adenocarcinoma: current perspectives;Soreide;Therapeut Clin Risk Manag,2019

4. Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer;Baek;BMC Gastroenterol,2011

5. Carcinoma of the stomach with hepatocyte differentiation (hepatoid adenocarcinoma);Roberts;Mayo Clin Proc,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP